New Tech Scrutiny and Support in Latest Medicare Inpatient Proposal

article image

CMS extends some new-technology add-on payments to make up for time lost to COVID, but it rules EUA devices can’t get NTAPs. That and more key takeaways from the FY 2022 hospital inpatient proposed rule.

The latest Medicare inpatient prospective payment system (IPPS) proposed rule is out, and it includes some noteworthy CMS new technology policies in the context of COVID-19, Breakthrough Devices, and AI. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: